nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—PTGS2—head and neck cancer	0.73	1	CbGaD
Aminosalicylic Acid—MPO—saliva—head and neck cancer	0.0051	0.155	CbGeAlD
Aminosalicylic Acid—Cutaneous hypersensitivity—Docetaxel—head and neck cancer	0.00422	0.0676	CcSEcCtD
Aminosalicylic Acid—Pericarditis—Fluorouracil—head and neck cancer	0.0033	0.0529	CcSEcCtD
Aminosalicylic Acid—Peptic ulcer—Vinblastine—head and neck cancer	0.00325	0.0521	CcSEcCtD
Aminosalicylic Acid—Eruption—Hydroxyurea—head and neck cancer	0.00323	0.0516	CcSEcCtD
Aminosalicylic Acid—CHUK—connective tissue—head and neck cancer	0.00248	0.0753	CbGeAlD
Aminosalicylic Acid—CHUK—epithelium—head and neck cancer	0.00235	0.0715	CbGeAlD
Aminosalicylic Acid—Encephalopathy—Fluorouracil—head and neck cancer	0.00222	0.0356	CcSEcCtD
Aminosalicylic Acid—PTGS2—cartilage tissue—head and neck cancer	0.00215	0.0654	CbGeAlD
Aminosalicylic Acid—CHUK—lymphoid tissue—head and neck cancer	0.00181	0.0551	CbGeAlD
Aminosalicylic Acid—Eruption—Docetaxel—head and neck cancer	0.00168	0.0268	CcSEcCtD
Aminosalicylic Acid—CHUK—thyroid gland—head and neck cancer	0.00165	0.05	CbGeAlD
Aminosalicylic Acid—CHUK—head—head and neck cancer	0.00146	0.0444	CbGeAlD
Aminosalicylic Acid—ALOX5—connective tissue—head and neck cancer	0.0014	0.0424	CbGeAlD
Aminosalicylic Acid—Dermatitis atopic—Docetaxel—head and neck cancer	0.00139	0.0223	CcSEcCtD
Aminosalicylic Acid—Diflunisal—PTGS2—head and neck cancer	0.00124	0.427	CrCbGaD
Aminosalicylic Acid—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00119	0.0191	CcSEcCtD
Aminosalicylic Acid—MPO—connective tissue—head and neck cancer	0.00118	0.0359	CbGeAlD
Aminosalicylic Acid—Agranulocytosis—Vinblastine—head and neck cancer	0.00114	0.0182	CcSEcCtD
Aminosalicylic Acid—MPO—epithelium—head and neck cancer	0.00112	0.0341	CbGeAlD
Aminosalicylic Acid—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00109	0.0174	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00104	0.0166	CcSEcCtD
Aminosalicylic Acid—CHUK—lymph node—head and neck cancer	0.00102	0.0311	CbGeAlD
Aminosalicylic Acid—ALOX5—lymphoid tissue—head and neck cancer	0.00102	0.031	CbGeAlD
Aminosalicylic Acid—Mesalazine—PTGS2—head and neck cancer	0.000972	0.335	CrCbGaD
Aminosalicylic Acid—ALOX5—thyroid gland—head and neck cancer	0.000927	0.0282	CbGeAlD
Aminosalicylic Acid—Anaemia—Vinblastine—head and neck cancer	0.000879	0.0141	CcSEcCtD
Aminosalicylic Acid—PTGS2—mouth—head and neck cancer	0.000874	0.0266	CbGeAlD
Aminosalicylic Acid—MPO—lymphoid tissue—head and neck cancer	0.000864	0.0262	CbGeAlD
Aminosalicylic Acid—Leukopenia—Vinblastine—head and neck cancer	0.000851	0.0136	CcSEcCtD
Aminosalicylic Acid—ALOX5—head—head and neck cancer	0.000823	0.025	CbGeAlD
Aminosalicylic Acid—Anaemia—Hydroxyurea—head and neck cancer	0.000802	0.0128	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000783	0.0125	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Hydroxyurea—head and neck cancer	0.000776	0.0124	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Vinblastine—head and neck cancer	0.00076	0.0122	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000748	0.012	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Fluorouracil—head and neck cancer	0.000746	0.0119	CcSEcCtD
Aminosalicylic Acid—Anorexia—Vinblastine—head and neck cancer	0.00074	0.0118	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000733	0.0117	CcSEcCtD
Aminosalicylic Acid—MPO—head—head and neck cancer	0.000696	0.0211	CbGeAlD
Aminosalicylic Acid—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000694	0.0111	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000693	0.0111	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—PTGS2—head and neck cancer	0.000689	0.238	CrCbGaD
Aminosalicylic Acid—Skin disorder—Hydroxyurea—head and neck cancer	0.000688	0.011	CcSEcCtD
Aminosalicylic Acid—Anorexia—Hydroxyurea—head and neck cancer	0.000675	0.0108	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Vinblastine—head and neck cancer	0.000675	0.0108	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000635	0.0102	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Hydroxyurea—head and neck cancer	0.000615	0.00985	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Vinblastine—head and neck cancer	0.000614	0.00982	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000611	0.00978	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Docetaxel—head and neck cancer	0.000585	0.00937	CcSEcCtD
Aminosalicylic Acid—Anaemia—Fluorouracil—head and neck cancer	0.000577	0.00924	CcSEcCtD
Aminosalicylic Acid—ALOX5—lymph node—head and neck cancer	0.000576	0.0175	CbGeAlD
Aminosalicylic Acid—Hypersensitivity—Vinblastine—head and neck cancer	0.000572	0.00916	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000565	0.00905	CcSEcCtD
Aminosalicylic Acid—Jaundice—Docetaxel—head and neck cancer	0.000562	0.009	CcSEcCtD
Aminosalicylic Acid—PTGS1—connective tissue—head and neck cancer	0.00056	0.017	CbGeAlD
Aminosalicylic Acid—Body temperature increased—Hydroxyurea—head and neck cancer	0.00056	0.00896	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Fluorouracil—head and neck cancer	0.000559	0.00895	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Docetaxel—head and neck cancer	0.000538	0.00861	CcSEcCtD
Aminosalicylic Acid—PTGS2—connective tissue—head and neck cancer	0.000536	0.0163	CbGeAlD
Aminosalicylic Acid—PTGS1—epithelium—head and neck cancer	0.000532	0.0162	CbGeAlD
Aminosalicylic Acid—Diarrhoea—Vinblastine—head and neck cancer	0.000531	0.0085	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000522	0.00835	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Docetaxel—head and neck cancer	0.000518	0.00829	CcSEcCtD
Aminosalicylic Acid—Dizziness—Vinblastine—head and neck cancer	0.000513	0.00822	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Docetaxel—head and neck cancer	0.000511	0.00818	CcSEcCtD
Aminosalicylic Acid—PTGS2—epithelium—head and neck cancer	0.000509	0.0154	CbGeAlD
Aminosalicylic Acid—Urethral disorder—Docetaxel—head and neck cancer	0.000507	0.00812	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Fluorouracil—head and neck cancer	0.0005	0.008	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000499	0.00799	CcSEcCtD
Aminosalicylic Acid—Vomiting—Vinblastine—head and neck cancer	0.000494	0.0079	CcSEcCtD
Aminosalicylic Acid—MPO—lymph node—head and neck cancer	0.000487	0.0148	CbGeAlD
Aminosalicylic Acid—Headache—Vinblastine—head and neck cancer	0.000486	0.00778	CcSEcCtD
Aminosalicylic Acid—Anorexia—Fluorouracil—head and neck cancer	0.000486	0.00778	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Hydroxyurea—head and neck cancer	0.000484	0.00775	CcSEcCtD
Aminosalicylic Acid—PTGS1—trachea—head and neck cancer	0.00047	0.0143	CbGeAlD
Aminosalicylic Acid—Dizziness—Hydroxyurea—head and neck cancer	0.000468	0.00749	CcSEcCtD
Aminosalicylic Acid—Nausea—Vinblastine—head and neck cancer	0.000461	0.00738	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Docetaxel—head and neck cancer	0.000451	0.00721	CcSEcCtD
Aminosalicylic Acid—Vomiting—Hydroxyurea—head and neck cancer	0.00045	0.00721	CcSEcCtD
Aminosalicylic Acid—PTGS2—trachea—head and neck cancer	0.00045	0.0137	CbGeAlD
Aminosalicylic Acid—Rash—Hydroxyurea—head and neck cancer	0.000446	0.00715	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Hydroxyurea—head and neck cancer	0.000446	0.00714	CcSEcCtD
Aminosalicylic Acid—Headache—Hydroxyurea—head and neck cancer	0.000443	0.0071	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Fluorouracil—head and neck cancer	0.000443	0.00709	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Docetaxel—head and neck cancer	0.000441	0.00706	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00044	0.00704	CcSEcCtD
Aminosalicylic Acid—Nausea—Hydroxyurea—head and neck cancer	0.000421	0.00673	CcSEcCtD
Aminosalicylic Acid—Anaemia—Docetaxel—head and neck cancer	0.000417	0.00667	CcSEcCtD
Aminosalicylic Acid—Urticaria—Fluorouracil—head and neck cancer	0.000405	0.00648	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Docetaxel—head and neck cancer	0.000403	0.00646	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Fluorouracil—head and neck cancer	0.000403	0.00645	CcSEcCtD
Aminosalicylic Acid—PTGS2—lymphoid tissue—head and neck cancer	0.000392	0.0119	CbGeAlD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000381	0.0061	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Fluorouracil—head and neck cancer	0.000375	0.00601	CcSEcCtD
Aminosalicylic Acid—PTGS1—thyroid gland—head and neck cancer	0.000372	0.0113	CbGeAlD
Aminosalicylic Acid—Nervous system disorder—Docetaxel—head and neck cancer	0.000361	0.00577	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Docetaxel—head and neck cancer	0.00036	0.00576	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Docetaxel—head and neck cancer	0.000357	0.00572	CcSEcCtD
Aminosalicylic Acid—Anorexia—Docetaxel—head and neck cancer	0.000351	0.00561	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Fluorouracil—head and neck cancer	0.000349	0.00558	CcSEcCtD
Aminosalicylic Acid—Dizziness—Fluorouracil—head and neck cancer	0.000337	0.00539	CcSEcCtD
Aminosalicylic Acid—PTGS1—head—head and neck cancer	0.00033	0.01	CbGeAlD
Aminosalicylic Acid—Vomiting—Fluorouracil—head and neck cancer	0.000324	0.00519	CcSEcCtD
Aminosalicylic Acid—Rash—Fluorouracil—head and neck cancer	0.000321	0.00514	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Fluorouracil—head and neck cancer	0.000321	0.00514	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Docetaxel—head and neck cancer	0.00032	0.00512	CcSEcCtD
Aminosalicylic Acid—Headache—Fluorouracil—head and neck cancer	0.000319	0.00511	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000318	0.00508	CcSEcCtD
Aminosalicylic Acid—PTGS2—head—head and neck cancer	0.000316	0.00959	CbGeAlD
Aminosalicylic Acid—Nausea—Fluorouracil—head and neck cancer	0.000303	0.00485	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000301	0.00481	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Docetaxel—head and neck cancer	0.000291	0.00465	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Docetaxel—head and neck cancer	0.000291	0.00465	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Docetaxel—head and neck cancer	0.000271	0.00434	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Docetaxel—head and neck cancer	0.000252	0.00403	CcSEcCtD
Aminosalicylic Acid—Dizziness—Docetaxel—head and neck cancer	0.000243	0.00389	CcSEcCtD
Aminosalicylic Acid—Vomiting—Docetaxel—head and neck cancer	0.000234	0.00374	CcSEcCtD
Aminosalicylic Acid—Rash—Docetaxel—head and neck cancer	0.000232	0.00371	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Docetaxel—head and neck cancer	0.000232	0.00371	CcSEcCtD
Aminosalicylic Acid—PTGS1—lymph node—head and neck cancer	0.000231	0.00702	CbGeAlD
Aminosalicylic Acid—Headache—Docetaxel—head and neck cancer	0.00023	0.00369	CcSEcCtD
Aminosalicylic Acid—PTGS2—lymph node—head and neck cancer	0.000221	0.00671	CbGeAlD
Aminosalicylic Acid—Nausea—Docetaxel—head and neck cancer	0.000218	0.0035	CcSEcCtD
Aminosalicylic Acid—CHUK—Downstream signal transduction—MAPK3—head and neck cancer	0.000144	0.00084	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—MAPK1—head and neck cancer	0.000144	0.000837	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—EGFR—head and neck cancer	0.000144	0.000837	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—MAPK3—head and neck cancer	0.000144	0.000836	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—MAPK3—head and neck cancer	0.000143	0.000832	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—MAPK3—head and neck cancer	0.000142	0.000828	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI3K/AKT activation—AKT1—head and neck cancer	0.000141	0.000823	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—AKT1—head and neck cancer	0.00014	0.000816	CbGpPWpGaD
Aminosalicylic Acid—CHUK—GAB1 signalosome—AKT1—head and neck cancer	0.00014	0.000816	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—STAT3—head and neck cancer	0.00014	0.000815	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—PTEN—head and neck cancer	0.000139	0.000807	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—PTGS2—head and neck cancer	0.000138	0.000803	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—MAPK1—head and neck cancer	0.000137	0.000799	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—EGFR—head and neck cancer	0.000137	0.000799	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—STAT6—head and neck cancer	0.000137	0.000799	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—head and neck cancer	0.000137	0.000798	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—STAT3—head and neck cancer	0.000137	0.000797	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—MAPK1—head and neck cancer	0.000137	0.000795	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—EGFR—head and neck cancer	0.000137	0.000795	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IL2—head and neck cancer	0.000136	0.000794	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—MAPK1—head and neck cancer	0.000136	0.000792	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—EGFR—head and neck cancer	0.000136	0.000791	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—MAPK1—head and neck cancer	0.000135	0.000788	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—EGFR—head and neck cancer	0.000135	0.000788	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—PIK3CA—head and neck cancer	0.000134	0.00078	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—MAPK3—head and neck cancer	0.000134	0.000779	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—MAPK3—head and neck cancer	0.000134	0.000779	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—MAPK3—head and neck cancer	0.000134	0.000779	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—EGFR—head and neck cancer	0.000133	0.000776	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000133	0.000775	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—CCND1—head and neck cancer	0.000133	0.000774	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—MAPK3—head and neck cancer	0.000133	0.000772	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—PIK3CA—head and neck cancer	0.000133	0.000771	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—MAPK3—head and neck cancer	0.000131	0.000765	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—MAPK3—head and neck cancer	0.000131	0.000762	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—MAPK1—head and neck cancer	0.000127	0.000741	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—MAPK1—head and neck cancer	0.000127	0.000741	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—MAPK1—head and neck cancer	0.000127	0.000741	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—EGFR—head and neck cancer	0.000127	0.000741	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—EGFR—head and neck cancer	0.000127	0.000741	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—EGFR—head and neck cancer	0.000127	0.000741	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—PIK3CA—head and neck cancer	0.000127	0.000738	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—MAPK1—head and neck cancer	0.000126	0.000734	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—EGFR—head and neck cancer	0.000126	0.000734	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000126	0.000733	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—MAPK1—head and neck cancer	0.000125	0.000728	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—EGFR—head and neck cancer	0.000125	0.000728	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000125	0.000727	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—PIK3CA—head and neck cancer	0.000125	0.000726	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—MAPK1—head and neck cancer	0.000125	0.000725	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—EGFR—head and neck cancer	0.000124	0.000725	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—STAT3—head and neck cancer	0.000124	0.000722	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000123	0.000715	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—HRAS—head and neck cancer	0.000123	0.000714	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000121	0.000707	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—TP53—head and neck cancer	0.000121	0.000706	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—HRAS—head and neck cancer	0.000121	0.000702	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—PTEN—head and neck cancer	0.00012	0.0007	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.00012	0.000697	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.00012	0.000697	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—PIK3CA—head and neck cancer	0.000119	0.000694	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—PIK3CA—head and neck cancer	0.000119	0.00069	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—MAPK3—head and neck cancer	0.000119	0.00069	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—PIK3CA—head and neck cancer	0.000118	0.000687	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—EGFR—head and neck cancer	0.000118	0.000686	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—PIK3CA—head and neck cancer	0.000117	0.000684	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—HRAS—head and neck cancer	0.000117	0.000683	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—head and neck cancer	0.000116	0.000674	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—HRAS—head and neck cancer	0.000115	0.000672	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL2—head and neck cancer	0.000115	0.000671	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—MAPK1—head and neck cancer	0.000113	0.000656	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—EGFR—head and neck cancer	0.000113	0.000656	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KISS1—head and neck cancer	0.000111	0.000646	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—PIK3CA—head and neck cancer	0.00011	0.000643	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—PIK3CA—head and neck cancer	0.00011	0.000643	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—PIK3CA—head and neck cancer	0.00011	0.000643	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—HRAS—head and neck cancer	0.00011	0.000642	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—HRAS—head and neck cancer	0.00011	0.00064	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—HRAS—head and neck cancer	0.00011	0.000639	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—MAPK3—head and neck cancer	0.00011	0.000638	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—AKT1—head and neck cancer	0.00011	0.000637	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—PIK3CA—head and neck cancer	0.000109	0.000637	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—HRAS—head and neck cancer	0.000109	0.000635	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—HRAS—head and neck cancer	0.000109	0.000632	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—PIK3CA—head and neck cancer	0.000109	0.000632	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—AKT1—head and neck cancer	0.000108	0.00063	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—PIK3CA—head and neck cancer	0.000108	0.000629	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—head and neck cancer	0.000107	0.000623	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—PTEN—head and neck cancer	0.000107	0.000621	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—AKT1—head and neck cancer	0.000106	0.00062	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000106	0.000616	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000105	0.000613	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—BCL2L1—head and neck cancer	0.000105	0.000609	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—MAPK1—head and neck cancer	0.000104	0.000607	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—EGFR—head and neck cancer	0.000104	0.000607	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000104	0.000605	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—AKT1—head and neck cancer	0.000104	0.000603	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.000102	0.000596	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—PIK3CA—head and neck cancer	0.000102	0.000595	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—HRAS—head and neck cancer	0.000102	0.000595	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—HRAS—head and neck cancer	0.000102	0.000595	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—HRAS—head and neck cancer	0.000102	0.000595	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—AKT1—head and neck cancer	0.000102	0.000593	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—HRAS—head and neck cancer	0.000101	0.00059	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000101	0.000585	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—HRAS—head and neck cancer	0.0001	0.000584	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—HRAS—head and neck cancer	0.0001	0.000582	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—PIK3CA—head and neck cancer	9.79e-05	0.00057	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—AKT1—head and neck cancer	9.74e-05	0.000567	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—STAT3—head and neck cancer	9.7e-05	0.000565	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—TYMS—head and neck cancer	9.7e-05	0.000565	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—AKT1—head and neck cancer	9.69e-05	0.000564	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—AKT1—head and neck cancer	9.64e-05	0.000561	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—AKT1—head and neck cancer	9.59e-05	0.000558	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—GSTM1—head and neck cancer	9.59e-05	0.000558	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—STAT3—head and neck cancer	9.54e-05	0.000555	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—HRAS—head and neck cancer	9.46e-05	0.000551	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—AKT1—head and neck cancer	9.46e-05	0.00055	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—MAPK3—head and neck cancer	9.27e-05	0.00054	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—GPX1—head and neck cancer	9.19e-05	0.000535	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GRP—head and neck cancer	9.14e-05	0.000532	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—MAPK3—head and neck cancer	9.12e-05	0.000531	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CYP1A1—head and neck cancer	9.09e-05	0.000529	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—HRAS—head and neck cancer	9.05e-05	0.000527	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	9.04e-05	0.000526	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—AKT1—head and neck cancer	9.03e-05	0.000525	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—AKT1—head and neck cancer	9.03e-05	0.000525	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—AKT1—head and neck cancer	9.03e-05	0.000525	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—AKT1—head and neck cancer	8.94e-05	0.000521	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	8.94e-05	0.000521	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—STAT6—head and neck cancer	8.87e-05	0.000516	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—AKT1—head and neck cancer	8.87e-05	0.000516	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	8.85e-05	0.000515	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—AKT1—head and neck cancer	8.83e-05	0.000514	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—MAPK1—head and neck cancer	8.82e-05	0.000513	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TP53—head and neck cancer	8.76e-05	0.00051	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	8.73e-05	0.000508	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—MAPK1—head and neck cancer	8.67e-05	0.000505	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—EGFR—head and neck cancer	8.67e-05	0.000505	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CASP8—head and neck cancer	8.56e-05	0.000498	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	8.49e-05	0.000494	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—PIK3CA—head and neck cancer	8.49e-05	0.000494	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—NAT2—head and neck cancer	8.42e-05	0.00049	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—AKT1—head and neck cancer	8.35e-05	0.000486	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CDH1—head and neck cancer	8.12e-05	0.000473	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—head and neck cancer	7.99e-05	0.000465	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	7.88e-05	0.000459	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—YAP1—head and neck cancer	7.85e-05	0.000457	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—PIK3CA—head and neck cancer	7.66e-05	0.000446	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—PIK3CA—head and neck cancer	7.53e-05	0.000438	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	7.47e-05	0.000435	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	7.46e-05	0.000434	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—DPYD—head and neck cancer	7.38e-05	0.00043	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—BCL2—head and neck cancer	7.34e-05	0.000427	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	7.1e-05	0.000413	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	7.1e-05	0.000413	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	7.1e-05	0.000413	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—HRAS—head and neck cancer	7.08e-05	0.000412	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	7.03e-05	0.000409	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—YAP1—head and neck cancer	7.01e-05	0.000408	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—HRAS—head and neck cancer	6.96e-05	0.000405	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—AKT1—head and neck cancer	6.93e-05	0.000404	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NAT2—head and neck cancer	6.68e-05	0.000389	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	6.16e-05	0.000358	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—AKT1—head and neck cancer	6.15e-05	0.000358	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—BCL2L1—head and neck cancer	6.1e-05	0.000355	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—PTEN—head and neck cancer	6.08e-05	0.000354	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	5.96e-05	0.000347	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—DPYD—head and neck cancer	5.86e-05	0.000341	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PTEN—head and neck cancer	5.84e-05	0.00034	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—YAP1—head and neck cancer	5.56e-05	0.000324	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PTGS2—head and neck cancer	5.41e-05	0.000315	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.26e-05	0.000306	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—MAPK3—head and neck cancer	5.2e-05	0.000303	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NOTCH1—head and neck cancer	5.05e-05	0.000294	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	5.03e-05	0.000293	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CASP8—head and neck cancer	4.99e-05	0.00029	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—MAPK1—head and neck cancer	4.95e-05	0.000288	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—EGFR—head and neck cancer	4.95e-05	0.000288	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CDH1—head and neck cancer	4.93e-05	0.000287	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—EGFR—head and neck cancer	4.75e-05	0.000276	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PTEN—head and neck cancer	4.72e-05	0.000274	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.59e-05	0.000267	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—PIK3CA—head and neck cancer	4.29e-05	0.00025	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—BCL2—head and neck cancer	4.28e-05	0.000249	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—TYMS—head and neck cancer	4.21e-05	0.000245	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GSTM1—head and neck cancer	4.16e-05	0.000242	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PIK3CA—head and neck cancer	4.12e-05	0.00024	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GPX1—head and neck cancer	3.98e-05	0.000232	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—HRAS—head and neck cancer	3.97e-05	0.000231	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYP1A1—head and neck cancer	3.94e-05	0.000229	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HRAS—head and neck cancer	3.81e-05	0.000222	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL2—head and neck cancer	3.77e-05	0.000219	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTGS2—head and neck cancer	3.75e-05	0.000218	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.64e-05	0.000212	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PTEN—head and neck cancer	3.54e-05	0.000206	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NOTCH1—head and neck cancer	3.54e-05	0.000206	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—AKT1—head and neck cancer	3.51e-05	0.000204	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—AKT1—head and neck cancer	3.37e-05	0.000196	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—TYMS—head and neck cancer	3.34e-05	0.000194	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PIK3CA—head and neck cancer	3.33e-05	0.000194	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GSTM1—head and neck cancer	3.3e-05	0.000192	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTEN—head and neck cancer	3.27e-05	0.00019	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.24e-05	0.000189	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—STAT3—head and neck cancer	3.17e-05	0.000184	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GPX1—head and neck cancer	3.16e-05	0.000184	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP1A1—head and neck cancer	3.13e-05	0.000182	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MAPK3—head and neck cancer	3.03e-05	0.000176	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOTCH1—head and neck cancer	2.99e-05	0.000174	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—STAT3—head and neck cancer	2.93e-05	0.00017	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MAPK1—head and neck cancer	2.88e-05	0.000168	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—EGFR—head and neck cancer	2.88e-05	0.000168	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MAPK3—head and neck cancer	2.8e-05	0.000163	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—AKT1—head and neck cancer	2.72e-05	0.000158	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MAPK1—head and neck cancer	2.66e-05	0.000155	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—EGFR—head and neck cancer	2.66e-05	0.000155	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.57e-05	0.00015	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PIK3CA—head and neck cancer	2.5e-05	0.000146	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL2—head and neck cancer	2.44e-05	0.000142	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCND1—head and neck cancer	2.37e-05	0.000138	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PTGS2—head and neck cancer	2.34e-05	0.000136	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HRAS—head and neck cancer	2.31e-05	0.000135	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PIK3CA—head and neck cancer	2.31e-05	0.000134	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTEN—head and neck cancer	2.29e-05	0.000133	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HRAS—head and neck cancer	2.14e-05	0.000124	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—VEGFA—head and neck cancer	2.07e-05	0.00012	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—STAT3—head and neck cancer	2.05e-05	0.000119	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PTEN—head and neck cancer	2.04e-05	0.000119	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—AKT1—head and neck cancer	2.04e-05	0.000119	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MAPK3—head and neck cancer	1.96e-05	0.000114	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PTEN—head and neck cancer	1.94e-05	0.000113	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—AKT1—head and neck cancer	1.89e-05	0.00011	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MAPK1—head and neck cancer	1.86e-05	0.000108	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EGFR—head and neck cancer	1.86e-05	0.000108	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—STAT3—head and neck cancer	1.73e-05	0.000101	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MAPK3—head and neck cancer	1.66e-05	9.64e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PTEN—head and neck cancer	1.62e-05	9.45e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CA—head and neck cancer	1.62e-05	9.41e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MAPK1—head and neck cancer	1.58e-05	9.17e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—EGFR—head and neck cancer	1.58e-05	9.17e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TP53—head and neck cancer	1.56e-05	9.1e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HRAS—head and neck cancer	1.5e-05	8.7e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CA—head and neck cancer	1.44e-05	8.4e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PIK3CA—head and neck cancer	1.37e-05	7.96e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AKT1—head and neck cancer	1.32e-05	7.69e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HRAS—head and neck cancer	1.27e-05	7.36e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—AKT1—head and neck cancer	1.18e-05	6.86e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CA—head and neck cancer	1.15e-05	6.67e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—AKT1—head and neck cancer	1.12e-05	6.5e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AKT1—head and neck cancer	9.36e-06	5.44e-05	CbGpPWpGaD
